Clinsight AB
AI platform revolutionizing prostate cancer diagnosis and risk prediction.
Översikt
- 0
- Anställda
- ≤1t SEK
- Omsättning
- 2022
- Grundat
Nyckelbeslutsfattare
Stefan Almestrand
Board executive
Martin Eklund
CEO
Nita Mulliqi
Head of AI
Anna Dimitrova
CFO
+2 fler kontakter i Funnelfeedr
Beskrivning
Clinsight is a HealthTech company dedicated to revolutionizing clinical decision-making in prostate cancer diagnosis.\nThey have developed ClinAI™, an autonomous AI-powered analysis tool for standard biopsy slides.\nThis technology provides outcome-based risk prediction and precise Gleason scoring,...